Research ArticleArticle
Altered Drug Interaction and Regulation of Topoisomerase IIβ: Potential Mechanisms Governing Sensitivity of HL-60 Cells to Amsacrine and Etoposide
Dale R. Grabowski, Katherine A. Holmes, Masako Aoyama, Ying Ye, Lisa A. Rybicki, Ronald M. Bukowski, Mahrukh K. Ganapathi, Ian D. Hickson and Ram Ganapathi
Molecular Pharmacology December 1999, 56 (6) 1340-1345; DOI: https://doi.org/10.1124/mol.56.6.1340
Dale R. Grabowski
Experimental Therapeutics Program, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio; and the Molecular Oncology Laboratory, Imperial Cancer Research Fund Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom
Katherine A. Holmes
Experimental Therapeutics Program, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio; and the Molecular Oncology Laboratory, Imperial Cancer Research Fund Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom
Masako Aoyama
Experimental Therapeutics Program, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio; and the Molecular Oncology Laboratory, Imperial Cancer Research Fund Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom
Ying Ye
Experimental Therapeutics Program, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio; and the Molecular Oncology Laboratory, Imperial Cancer Research Fund Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom
Lisa A. Rybicki
Experimental Therapeutics Program, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio; and the Molecular Oncology Laboratory, Imperial Cancer Research Fund Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom
Ronald M. Bukowski
Experimental Therapeutics Program, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio; and the Molecular Oncology Laboratory, Imperial Cancer Research Fund Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom
Mahrukh K. Ganapathi
Experimental Therapeutics Program, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio; and the Molecular Oncology Laboratory, Imperial Cancer Research Fund Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom
Ian D. Hickson
Experimental Therapeutics Program, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio; and the Molecular Oncology Laboratory, Imperial Cancer Research Fund Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom
Ram Ganapathi
Experimental Therapeutics Program, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio; and the Molecular Oncology Laboratory, Imperial Cancer Research Fund Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Altered Drug Interaction and Regulation of Topoisomerase IIβ: Potential Mechanisms Governing Sensitivity of HL-60 Cells to Amsacrine and Etoposide
Dale R. Grabowski, Katherine A. Holmes, Masako Aoyama, Ying Ye, Lisa A. Rybicki, Ronald M. Bukowski, Mahrukh K. Ganapathi, Ian D. Hickson and Ram Ganapathi
Molecular Pharmacology December 1, 1999, 56 (6) 1340-1345; DOI: https://doi.org/10.1124/mol.56.6.1340
Research ArticleArticle
Altered Drug Interaction and Regulation of Topoisomerase IIβ: Potential Mechanisms Governing Sensitivity of HL-60 Cells to Amsacrine and Etoposide
Dale R. Grabowski, Katherine A. Holmes, Masako Aoyama, Ying Ye, Lisa A. Rybicki, Ronald M. Bukowski, Mahrukh K. Ganapathi, Ian D. Hickson and Ram Ganapathi
Molecular Pharmacology December 1, 1999, 56 (6) 1340-1345; DOI: https://doi.org/10.1124/mol.56.6.1340
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement